Fast Five Quiz: How Well Do You Know the Risk Factors and Treatment Indications for Type 2 Diabetes Mellitus?

Romesh Khardori, MD, PhD

Disclosures

April 25, 2017

Although the long-term benefits and harms of diabetes medications remain unclear, the evidence supports the use of metformin as a first-line agent. On average, monotherapy with many of the oral diabetes drugs reduces A1c levels by 1 percentage point (although metformin has been found to be more efficacious than the dipeptidyl peptidase-4 inhibitors), and two-drug combination therapies reduce A1c about 1 percentage point more than do monotherapies.

For more on the treatment of type 2 diabetes mellitus, read here.

Related Resources

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as:

processing....